No Detail Found!

Natural growth sesquiterpene of glioblastoma zingiberene exerts cells by instigating ameliorative effects on ROS mediated apoptosis

Author(s)
Talib Hussain Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia
Ahmed Alafnan Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia
Syed Mohd Danish Rizvi Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia
Afrasim Moin Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia
Sirajudheen Anwar Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia
Abd Elmoneim Osman Elkhalifa Department of Clinical Nutrition, College of Applied Medical Sciences, University of Hail, Ha'il, Saudi Arabia
Amir Mahgoub Awadelkareem Department of Clinical Nutrition, College of Applied Medical Sciences, University of Hail, Ha'il, Saudi Arabia
Salman Khan Nanotechnology and Nanomedicine Lab-6 (IIRC), Department of Biosciences, Infegral University. Lucknow, India
Ahmed Adel Katamesh Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia; SDepartment of Pharmaceutics, Central Administration for Drug Control, Egyptian Drug Authority “EDA”, Giza, Egypt
Abstract
Glioblastoma multiforme is the most aggressive and invasive primary brain tumor in adults, and its prognosis and survival rate remain poor. Despite substantial improvements in therapy, the 5-year survival rate of glioblastoma patients remains low. Sesquiterpenes have previously been found to be effective in inhibiting the proliferation and growth of breast, gastric, and lung cancer cells. Owing to their efficacy, sesquiterpenes have been used in various clinical trials. In the present study, we investigated the anticancer efficacy of a well-known sesquiterpene, Zingiberene, isolated from Zingiber officinale in C6 glioblastoma cells. Zingiberene suppresses the growth and proliferation of C6 cells. Upon treatment of C6 cells with zingiberene, nuclear fragmentation and ROS were qualitatively enhanced compared to untreated control cells. The levels of caspase-3 were also significantly reduced (p<0.01), with a concomitant decline in the mRNA expression of Bax and Bel-2. On the basis of molecular docking studies, Zingiberene demonstrated good binding energy score of -6.8 and -5.5 Kcal/mol towards Bax and Bcl-2 proteins, respectively. Based on these observations, it was inferred that zingiberene has potential as a plausible therapeutic agent against glioblastoma cells. Detailed mechanistic studies are needed to substantiate and establish the anticancer effects of zingiberene against glioblastoma cells.
Publication Details
Page(s) 939-948
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Apoptosis, Glioblastoma multiforme, Zingiberine, ROS
0

Citations

0

Downloads

201

Views